ADAP logo

Adaptimmune Therapeutics (ADAP) Enterprise Value

Enterprise Value

$138.74 M
+$2.56 M+1.88%

Thu, 28 Nov 2024 00:56:32 GMT

ADAP Enterprise Value Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADAP Enterprise Value Performance

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday+1.9%+1.4%+1.4%
1 m1 month--6.0%-6.1%
3 m3 months-6.0%-42.0%-42.0%
6 m6 months-5.1%-31.2%-31.3%
ytdytd+128.5%+0.8%-10.5%
1 y1 year+266.2%+76.8%+57.0%
5 y5 years+61.4%+80.2%-25.9%

ADAP Enterprise Value High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1 month$139 Mat high$111 M+24.7%
3 m3 months$165 M-16.1%$74 M+87.6%
6 m6 months$199 M-30.1%$74 M+87.6%
1 y1 year$335 M-58.6%$37 M+279.7%
3 y3 years$631 M-78.0%$31 M+348.2%
5 y5 years$1.69 B-91.8%$31 M+348.2%
alltimeall time$1.69 B-91.8%$31 M+348.2%

Adaptimmune Therapeutics Enterprise Value History

DateValue
2024
$138.74 M(+128.5%)
2023
$60.71 M(-60.0%)
2022
$151.70 M(-67.1%)
2021
$461.49 M(-42.4%)
2020
$801.16 M(+691.3%)
DateValue
2019
$101.25 M(-81.0%)
2018
$532.93 M(-1.6%)
2017
$541.78 M(+323.5%)
2016
$127.94 M(-79.9%)
2015
$636.60 M

FAQ

  • What is Adaptimmune Therapeutics enterprise value?
  • What is the all time high enterprise value for Adaptimmune Therapeutics?
  • What is ADAP enterprise value year-to-date change?
  • What is Adaptimmune Therapeutics enterprise value year-on-year change?

What is Adaptimmune Therapeutics enterprise value?

The current enterprise value of ADAP is $138.74 M

What is the all time high enterprise value for Adaptimmune Therapeutics?

Adaptimmune Therapeutics all-time high enterprise value is $1.69 B

What is ADAP enterprise value year-to-date change?

Adaptimmune Therapeutics enterprise value has changed by +$78.03 M (+128.54%) since the beginning of the year

What is Adaptimmune Therapeutics enterprise value year-on-year change?

Over the past year, ADAP enterprise value has changed by +$100.86 M (+266.23%)